Tina Cubeta
Nurse Practitioner · Wilmington, DENPI 1184907743
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 193 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$858
- Otsuka America Pharmaceutical, Inc.$549
- AbbVie$523
- Axsome Therapeutics, Inc.$424
- Lundbeck LLC$314
- Johnson & Johnson$296
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,40297%
- Education$1313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $858 |
| Otsuka America Pharmaceutical, Inc. | 22 | $549 |
| AbbVie | 23 | $523 |
| Axsome Therapeutics, Inc. | 14 | $424 |
| Lundbeck LLC | 16 | $314 |
| Johnson & Johnson | 21 | $296 |
| Neurocrine Biosciences, Inc. | 11 | $253 |
| Alkermes, Inc. | 16 | $217 |
| E.r. Squibb & Sons, L.L.C. | 3 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $208 |
| Vanda Pharmaceuticals Inc. | 5 | $201 |
| Corium, LLC | 5 | $105 |
| Sunovion Pharmaceuticals Inc. | 5 | $77 |
| Biogen | 1 | $70 |
| Sage Therapeutics, LLC | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Bausch Health US, LLC | 2 | $30 |
| Tris Pharma Inc | 2 | $27 |
| Neos Therapeutics, LP | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,532 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Wilmington
- Colleen DitroWilmington$16K
- Jennifer HubbardWilmington$12K
- Monica SamWilmington$7K
- Brenda NardozziWilmington$7K
- Ellen NeffWilmington$5K
- Auxilia AkalaWilmington$3K
- Melissa LehrWilmington$3K
- Cathy RamageWilmington$2K
- Meghan McCarterSeaford$170K
- Chandni PatelMiddletown$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.